Australia
Australia deal-by-deal player Alceon sees investment uptick
Australia-based deal-by-deal investor Alceon Private Equity expects to complete four investments this year, having expanded its scope from consumer and retail to include healthcare, childcare, and IT services.
HESTA backs PEP-owned Australia software business
HESTA has acquired a A$120 million ($85 million) equity stake in Australian enterprise software and IT services provider Citadel, following its merger with medical practice software specialist Genie Solutions.
K1, Level Equity invest $350m in Australia SaaS player
US private equity firms K1 Investment Management and Level Equity have invested about $350 million in Australia’s Simpro, a software-as-a-service (SaaS) provider focused on field service management.
Australia's Five V sells GP stake
Australia-based Five V Capital has sold a 25% GP stake to Pinnacle Investment Management Group, a listed multi-affiliate platform investor that has interests in 14 Australian asset managers.
Deal focus: Icon retains its private equity appeal
EQT’s $1.67 billion acquisition of Icon Group underscores the recent trend in large-cap buyouts, as well as the long-term growth potential for cancer care specialists in Australia and the wider Asian region
Australia's Five V raises $398m for Fund IV
Five V Capital, a growth-oriented investor in Australia and New Zealand, has achieved a first and final close on its fourth fund with more than A$550 million ($398 million) in commitments.
EQT buys Australia cancer care business from PE consortium
Goldman Sachs Asset Management, QIC, and Pagoda Investment – a China-focused GP set up by a former QIC executive – have agreed to sell Australia cancer care provider Icon Group to EQT for a reported valuation of A$2.3 billion ($1.67 billion).
Australia's Allegro hits overall target with Fund IV first close
Allegro Funds, an Australia-based turnaround specialist, has reached a first close of A$600 million ($449 million) on its fourth fund, hitting the overall target for the vehicle.
Riverside backs Australia clinical trials business
The Riverside Company has acquired Avance Clinical, an Australia-based contract research organization (CRO) with a view to building out its clinical trials business.
Potentia exits Australia SaaS provider to UK strategic
Australia’s Potentia Capital has exited compliance software-as-a-service (SaaS) supplier CompliSpace to UK-based Ideagen for about A$110 million ($81 million) after a less-than-two-year hold.
Australia's Rampersand targets $29m for fourth VC fund
Rampersand, an Australia-based VC investor, is looking to raise A$40 million ($29.6 million) for its fourth fund, which will address what the firm describes as a “chronic funding gap in early-stage seed funding.”
Carlyle resumes pursuit of Australia's Link Group
The Carlyle Group has made a A$2.8 billion ($2.1 billion) buyout offer for Australia-based financial data and fund administration services provider Link Administration Holdings, six months after abandoning a joint bid for the company with Pacific Equity...
Australia's Glow seeks $222m for debut fund
Glow Capital Partners, an Australian private equity firm established by Justin Ryan, formerly of Quadrant Private Equity, and Kate Morris, founder of beauty e-commerce platform Adore Beauty, is targeting A$300 million ($222 million) for its debut fund....
Fund focus: Genesis reinforces Australia's specialist thesis
Having raised $142 million for its debut fund, Genesis Capital joins a select group of Australian mid-market GPs with blind pools. The firm believes a singular focus on healthcare was a key selling point
Blackstone buys Australia clinical trials specialist
The Blackstone Group has acquired Nucleus Network, which claims to be Australia’s largest phase-one clinical trials provider, for an undisclosed sum. It provides an exit for local GP Crescent Capital Partners.
Apollo bulks up credit team as part of Asia expansion
Apollo Global Management has recruited three professionals from Commonwealth Bank of Australia (CBA) to join its Asia Pacific credit business.
PE-owned APM Human Services set for $743m Australia IPO
APM Human Services, an Australia-based employment services provider with operations in 10 countries, is looking to raise A$986.2 million ($743 million) through a domestic IPO that will facilitate a partial exit for Madison Dearborn Partners (MDP).
LP interview: Cambooya
The family office that represents members of Australia’s Fairfax family launched its private equity program six years ago. Venture capital, growth equity, and co-investment are increasingly on the agenda
EIG pays $1.6b for 10% stake in Australia Pacific LNG
Energy and infrastructure investor EIG has acquired a 10% stake in Australia’s largest coal seam gas producer from domestic utility Origin Energy for A$2.12 billion ($1.59 billion).
Riverside adds to Australia workplace wellbeing rollup play
The Riverside Group has bought Australian injury management and occupational rehabilitation services provider Nabenet as part of a workplace wellbeing rollup strategy.
Australia's Allegro seeks $449m for Fund IV
Australia-based turnaround specialist Allegro Funds is targeting A$600 million ($449 million) for its fourth fund, more than twice what it raised in the previous vintage.
Q&A: Glow Capital Partners' Justin Ryan
Having teamed up with the founder of Adore Beauty to launch Glow Capital Partners, Justin Ryan discusses life after Quadrant Private Equity, growth-stage investment in Australia, and gender balance
Australian Business Growth Fund seals debut deal
The Australia Business Growth Fund (ABGF) has made its first investment, committing A$15 million ($11 million) to local lithium-ion battery manufacturer 3ME Technology.
